Global Multiple Myeloma Treatment Drugs Market to Grow with a Robust CAGR Throughout 2021-2029; Market to Expand Owing to Increasing Prevalence of the Disease and Rising Obese Population
Research
Nester released a report titled “Multiple
Myeloma Treatment Drugs Market: Global Demand Analysis & Opportunity
Outlook 2029” which delivers detailed overview of the global multiple
myeloma treatment drugs market in terms of market segmentation by drug class,
therapy, distribution channel, and by region.
Further,
for the in-depth analysis, the report encompasses the industry growth
indicators, restraints, supply and demand risk, along with detailed discussion
on current and future market trends that are associated with the growth of the
market.
The
multiple
myeloma treatment drugs market is
projected to grow at a robust CAGR during the forecast period, i.e., 2021-2029.
Despite of being a comparatively rare condition, the patient-pool of multiple
myeloma is assessed to increase significantly in the coming years, leading to
boost the market growth. As per our
analysis, more than 34,000 adults in the U.S.A are expected to be diagnosed
with multiple myeloma cancer in 2021, rising up from 32,200 incidences in 2020.
On
the basis of drug class, the global multiple myeloma treatment drugs market is
segmented into immmunomodulatory drugs (IMiDs), proteasome inhibitors, steroids,
monoclonal antibodies, and others. The segment for IMiDs is anticipated to hold
the largest share in the market in the year 2021 as a result of their high
success in showing positive treatment rates.
Download
Sample of This Strategic Report: https://www.researchnester.com/sample-request-2898
Geographically,
the market is segmented into North America, Europe, Asia Pacific, Latin America
and the Middle East & Africa region, out of which, the market in North
America is projected to grow at the highest rate and occupy the largest market share
in the year 2021. This can be credited to prominent technological advancements
with respect to multiple myeloma treatment, the presence of leading drug
manufacturers and high adoption of sophisticated cancer treatments in the
region.
Increasing Occurrence of Multiple
Myeloma
Numerous
researches from several external sources reveal that the total number of deaths
from multiple myeloma is expected to grow from 2021 onwards. This increasing
number of cases is associated with the rise in number of blood cancer cases in
general. Apart from this, growing demand for multiple
myeloma therapies, along with the surge in the
number of people suffering from obesity, which is also one of the primary causes
of cancer, are some of the additional factors projected to drive the market growth.
However,
the high cost of multiple myeloma treatment and lack of awareness about cancer
treatment in low-income economies are some of the factors estimated to limit
the progress of the market.
“The
Final Report will cover the impact analysis of COVID-19 on this industry.”
Download/Request Sample Copy of Strategic Report: https://www.researchnester.com/sample-request-2898
This
report also provides the existing competitive scenario of some of the key
players of the global multiple
myeloma treatment drugs market which
includes company profiling of Bristol-Myers Squibb Company (NYSE: BMY), Amgen Inc.
(NASDAQ: AMGN), Johnson & Johnson Services, Inc. (NYSE: JNJ), Merck Sharp &
Dohme Corp. (NYSE: MRK), Daiichi Sankyo Company, Limited (TYO: 4568), Pfizer
Inc. (NYSE: PFE), F. Hoffmann-La Roche Ltd (SWX: RO), Sanofi-aventis Groupe (EPA:
SAN), Novartis International AG (SWX: NOVN), and Pharma Mar, S.A. (BME:
PHM).
The profiling enfolds key information of the companies which encompasses
business overview, products and services, key financials and recent news and
developments. On the whole, the report depicts detailed overview of the global multiple myeloma treatment
drugs market that will help
industry consultants, equipment manufacturers, existing players searching for
expansion opportunities, new players searching possibilities and other
stakeholders to align their market centric strategies according to the ongoing
and expected trends in the future.
About
Research Nester
Research
Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market
research and consulting with an unbiased and unparalleled approach towards
helping global industrial players, conglomerates and executives for their
future investment while avoiding forthcoming uncertainties. With an
out-of-the-box mindset to produce statistical and analytical market research
reports, we provide strategic consulting so that our clients can make wise
business decisions with clarity while strategizing and planning for their
forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new
horizon, provided a right guidance at a right time is available through
strategic minds.
Contact
for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
Comments
Post a Comment